Source: TNMichele Wilson PhDScience Writer Immuno-transcriptomics is a field of study focused on analyzing gene expression modifications (mRNA signatures) induced by the immune response to various triggers, such as the onset of cancer. Through deep neural network and machine learning, Novigenix are generating mathematical models based on these mRNA signature analyses to predict the onset and progression
NEW YORK (GenomeWeb) – With a new CEO at its helm, Swiss molecular diagnostic firm Novigenix is developing a new version of Colox, its mRNA-based assay for early colorectal cancer detection that applies next-generation sequencing instead of RT-PCR. The firm began a study earlier this year to validate the assay, which measures cancer-specific transcriptomic
Novigenix Appoints Dr. Jan Groen as CEO to Lead Expansion to Multi-Product Cancer Diagnostic Platform Company
ImmunoTranscriptomic platform combines identification of immune cell mRNA signatures with AI for early cancer detection LAUSANNE, SWITZERLAND - 07:00 CET, May 13, 2019 - Novigenix SA, a leading ImmunoTranscriptomics company that develops and commercializes products for early cancer detection and precision medicine today announced the appointment of Dr. Jan Groen to the position of Chief
Our COO Nicolas Demierre is presenting at the Convergence in Oncology Summit our innovative and integrative approach based on blood transcriptomics and advanced data analytics for applications in early cancer detection. #Oncology #Innovation #COS2018 https://lnkd.in/dTaMBNa
Do you know that the majority of patients are diagnosed in late stage? Don’t wait for symptoms. Don’t wait to get screened !
Colox is implemented in routine medical practice in Switzerland. Come visit our website to learn more about Colox : www.novigenix.com
Colorectal cancer progresses slowly and doesn’t show signs or symptoms until an advanced stage1. Thus, people who get cancer are diagnosed late whereas an early detection increases the chances of survival. Even if we don't have to wait for the first symptoms to get screened, it is important to recognize the signs that may be associated to colorectal cancer.
PREVENTION : Colorectal cancer screening is voluntary but the physicians strongly recommend it Prof. Dr. med. Christoph Beglinger - Specialist of Gastroenterology Colorectal Cancer - Screening : Now, there are three options for the prevention. Switzerland lags behind regarding colorectal cancer screening, according to international comparison. Only 30% of men and women over the age of